Arrhythmias Flashcards

1
Q

describe cardiac arrhtymias

A

disturbances of heart rate, rhythm

describe in terms of rate;
bradycardia
tachycardia
describe in terms of origin;
supra-ventricular (atria and AV node)
ventricular
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe causes of cardiac arrhythmia

A

changes in;
impulse formation - changes in automaticity, triggered activity
impulse conduction - re-entry, conduction block, accessory tracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe changes in automaticity

A

SA is pacemaker (highest, 70-80 BPM, dominant over latent pacemakers) but all components of cardiac conduction system demonstrate a slower spontaneous phase 4 depolarisation and thus possess automaticity (AV node, 50-60 BPM, Purkinje fibres 30-40 BPM) => overdrive suppression

In order for the SA node to exert its normal control of rate and rhythm it must discharge action potentials at a regular frequency greater than any other structure in the heart
if not, the function of the SA node as normal pacemaker is taken over by another latent pacemaker as the result of loss of overdrive suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

describe loss of overdrive suppression

A

May occur if the SA node firing frequency is pathologically low, or if conduction of the impulse from the SA node is impaired;
latent pacemaker may initiate an impulse that generates an escape beat
a run of such impulses may give rise to an escape rhythm, a series of escape beats

May occur if a latent pacemaker fires at an intrinsic rate faster than the SA node rate (even if the SA node is functioning normally);
latent pacemaker initiates an ecoptic beat, or a series of such beats generating an ectopic rhythm (i.e. one not generated by the SA node – ectopic meaning in an abnormal place, or position)
ectopic rhythms can result from ischaemia, hypokalaemia, increased sympathetic activity, fibre stretch and other causes

Can occur in response to tissue damage (e.g. post myocardial infarction);
even non-pacemaker cells (i.e. myocytes), when partially depolarized, may assume spontaneous activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe triggered acitivty

A

A normal action potential may trigger abnormal oscillations in membrane potential termed afterdepolarizations (ADs) that occur during, or after, repolarization
ADs of amplitude sufficient to reach threshold cause premature action potentials and beats
Afterdepolarizations may be either (PP);
early afterdepolarizations (EADs)
delayed afterdepolarizations (DADs)

Repeated afterdepolarizations of either type may cause a sustained arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

describe early afterdepolarizations

A
occur during the inciting action potential within;
phase 2 (terminal plateau) – AD mediated by Ca2+ channels (when Na+ channels are still inactivated)
phase 3 (repolarization) – AD mediated by Na+ channels (when partial recovery of Na+ channels from inactivation has occurred)

are most likely to occur when heart rate is slow
often occur in Purkinje fibres
are associated with prolongation of the action potential and drugs (e.g. sotalol) prolonging the QT interval
when sustained can lead to the life threatening arrhythmia ‘torsades de pointes’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

describe delayed afterdepolarizations

A

occur after complete repolarization
are caused by large increases in [Ca2+]i
excessive [Ca2+]i results in;
oscillatory release of Ca2+ from the sarcoplasmic reticulum (SR)
a transient inward current (Iti, involving Na+-influx) that occurs in phase 4

are most likely to occur when heart rate is fast
are increased and decreased in incidence by prolongation and shortening of the duration of the action potential by drugs, respectively (predictably from alterations in Ca2+ influx during phase 2)
may be triggered by drugs that increase Ca2+ influx (e.g. catecholamines), or release, from the SR (e.g. digoxin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

describe defects in impulse conduction

A

re-entry
conduction block
accessory tracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe re-entry defect in impulse conduction

A
Self sustaining electrical circuit (anatomically may be two parallel conduction pathways), stimulates an area of myocardium repeatedly/rapidly
The re-entrant circuit requires;
unidirectional block
anterograde conduction prohibited
retrograde conduction allowed
slowed retrograde conduction velocity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe conduction block defect in impulse conduction - partial

A

partial - slowed conduction - tissue conducts all impulses but more slowly than usual
e.g. first degree AV block

intermittent block - tissue conducts some impulses, but not others
e.g. second degree AV block occurring as 2 types;
Mobitz type I – PR interval gradually increases from cycle to cycle until AV node fails completely and a ventricular beat is missed
Mobitz type II –PR interval is constant but every nth. ventricular depolarization is missing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

describe conduction block defect in impulse conduction - complete

A

no impulses are conducted through affected area
e.g. third degree AV block ;
atria and ventricles beat independently, governed by their own pacemakers
ventricular pacemaker is now the Purkinje fibres – fire relatively slowly and unreliably – manifest as bradycardia and low cardiac output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe accessory tract pathways

A

Some individuals possess electrical pathways in parallel to the AV node
a common pathway is the bundle of Kent
impulse through bundle of Kent is conducted more quickly than that through the AV node
ventricles receive impulses from both the normal and accessory pathways – can set up the condition for a re-entrant loop predisposing to tachyarrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

describe action of anti-arrhythmic drugs

A
inhibit specific ion channels (or activate/block specific receptors) with the intention of suppressing abnormal electrical activity  
classified pharmacologically based upon their effects upon the cardiac action potential (the Vaughn Williams classification  
The scheme defines four classes I, II, III and IV, with class I subdivided into subclasses Ia, Ib and Ic  
many antiarrhythmic agents are not entirely selective blockers of Na+, K+, or Ca2+ channels, and may block more than one channel type (e.g. amiodarone)
Some drugs do not fit in to the Vaughn Williams classification (e.g. adenosine, digoxin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe class I anti-arrhthmic drugs - IA

A

phase 0
rhythm control
acts on atria, ventricles, AV accessory pathways

targets voltage activated Na+ channel (PP);
Voltage-activated Na+ channels cycle between resting, open and inactivated (refractory) states. Relative proportions of time spent in each depend upon firing frequency
During high frequency firing (e.g. tachyarrhythmias) relatively more time is spent in the open and inactivated states. Class I agents bind preferential to these targeting areas of the myocardium in which firing frequency is highest in a use-dependent manner without preventing the heart from beating at normal frequencies

Associate with and dissociate from Na+ channels at a moderate rate. Slow rate of rise of AP and prolong refractory period

e.g. Disopyramide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

describe class I anti-arrhthmic drugs - IB

A

phase 0
rhythm control
acts on ventricles

targets voltage activated Na+ channel

Associate with and dissociate from Na+ channels at a rapid rate. Prevent premature beats

e.g. Lignocaine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

describe class I anti-arrhthmic drugs - IC

A

phase 0
rhythm control
acts on atria, ventricles, AV accessory pathways

targets voltage activated Na+ channel

Associate with and dissociate from Na+ channels at a slow rate. Depress conduction

e.g. Flecainide

17
Q

describe class I anti-arrhthmic drugs - II

A

depolarisation
rate control
acts on ventricles

beta-adrenoceptor (as antagonists)

Decrease rate of depolarization in SA and AV nodes

e.g. Metoprolol

18
Q

describe class I anti-arrhthmic drugs - III

A

repolarisation
rhythm control
acts on atria

Voltage-activated K+ channels (plus others)

Prolong AP duration increasing refractory period

e.g. Amiodarone

19
Q

describe class I anti-arrhthmic drugs - IV

A

phase 2 - plateua phase
rate control
acts on AV node

Voltage-activated Ca2+ channels

Slow conduction in SA and AV nodes. Decrease force of cardiac contraction

e.g. Verapamil

20
Q

describe how the dissociation rate of Class I Agents is an important determinant of steady-state block of Na+ channels

A

Class I agents dissociate from the Na+ channel when it is in the resting state (i.e. during diastole)
Thus, if heart rate increases, less time is available for unblocking (dissociation) and more time available for blocking (association). Steady state block increases, particularly for agents with slow dissociation rates
In ischaemic myocardium, myocytes are partially depolarized and the action potential is of longer duration thus:
the inactivated state of the Na+ channel is available to Na+ channel blockers for a greater period of time
the rate of channel recovery from block is decreased
Collectively the higher affinity of Na+ channel blockers for the open and inactivated states of the channel allows them to act preferentially on ischaemic tissue and block an arrhythmogenic focus at it source

21
Q

describe adenosine (IV blus)

A

drug used in supraventricular arrhythmias;
activates A1-adenosine receptors coupled to Gi/o;
Opens ACh-sensitive K+ channels (GIRK)
Hyperpolarizes the AV node briefly, suppressing impulse conduction
Used to terminate paroxysmal supraventricular tachycardia (PSVT – atrial firing rate of 140-250 beats per minute) caused by re-entry involving the AV node, SA node, or atrial tissue

22
Q

describe digoxin (IV infusion, oral)

A

Drugs used in Supraventricular Arrhythmias
stimulates vagal activity;
Slows conduction and prolongs refractory period in AV node and bundle of His
Used to treat atrial fibrillation (AF) – chaotic re-entrant impulse conduction through the atrium

23
Q

describe verapamil - type IV agent (Oral)

A

Drugs used in Supraventricular Arrhythmias
blocks L-type voltage-activated Ca2+ channels
Slows conduction and prolongs refractory period in AV node and bundle of His
Used to treat atrial flutter (AF) and fibrillation (AF) – chaotic re-entrant impulse conduction through the atria that may be conducted via the AV node to the ventricles
In high dose may cause heart block
Should be used with great caution in combination with other drugs that have a negative ionotropic effect
Largely replaced by adenosine for acute treatment, still used for prophylaxis

24
Q

describe lignocaine (type Ib agent)

A

drugs used in ventricular arrhythmias
rapid block of voltage-activated Na+ channels;
Blocks inactivated channels with little effect on open channels
Due to rapid unblocking primarily affects Na+ channels in areas of the myocardium that discharge action potentials at high rate (e.g. an ischaemic zone)
Is used mainly (IV) in the treatment of ventricular arrhythmias following a myocardial infarction

25
Q

describe disopyramide and procainamide (type Ia agents)

A

drugs used in arial and ventricular arrhythmias
moderate rate of block and unblock of voltage-activated Na+ channels;
Block open channels and are thus use-dependent
Moderate rate of dissociation results in insufficient time for unblocking if action potential frequency is high
Disopyramide is used (orally) to prevent recurrent ventricular arrhythmias, procainamide (IV) to treat ventricular arrhythmias following myocardial infarction

26
Q

describe flecainide (type Ic agent)

A

drugs used in atrial and ventricular arrhythmias
slow rate of block and unblock of voltage-activated Na+ channels;
Strongly depresses conduction in the myocardium and reduces contractility
Mainly used for prophylaxis of paroxysmal atrial fibrillation
Has negative ionotropic action and may trigger serious ventricular arrhythmias

27
Q

describe propanolol and atenolol (type II agents, beta blockers)

A

drugs used in atrial and ventricular arrhythmias
Control SVT by suppressing impulse conduction through the AV node
Supress excessive sympathetic drive that may trigger VT

28
Q

describe amiodarone and sotolol (type III agents)

A

drugs used in atrial and ventricular arrhythmias
slow repolarization of the AP by block of voltage-activated K+ channels and hence increase action potential duration and the effective refractory period;
Supress re-entry
Amiodarone is effective against SVT and VT, probably because it also has class IA, II and IV actions and also blocks β-adrenoceptors
Amiodarone is effective when many other drugs have failed and reduces mortality after MI and in congestive heart failure. However, long term use is compromised by many, serious, adverse effects that include:
pulmonary fibrosis
thyroid disorders
photosensitivity reactions
peripheral neuropathy